BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 18506086)

  • 1. Trefoil factor 3 (TFF3): a promising indicator for diagnosing thyroid follicular carcinoma.
    Takano T; Yamada H
    Endocr J; 2009; 56(1):9-16. PubMed ID: 18506086
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Aspiration biopsy-nucleic acid diagnosis for widely used preparative testing].
    Takano T
    Rinsho Byori; 2012 Feb; 60(2):132-8. PubMed ID: 22568094
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ADM3, TFF3 and LGALS3 are discriminative molecular markers in fine-needle aspiration biopsies of benign and malignant thyroid tumours.
    Karger S; Krause K; Gutknecht M; Schierle K; Graf D; Steinert F; Dralle H; Führer D
    Br J Cancer; 2012 Jan; 106(3):562-8. PubMed ID: 22223087
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Decreased relative expression level of trefoil factor 3 mRNA to galectin-3 mRNA distinguishes thyroid follicular carcinoma from adenoma.
    Takano T; Miyauchi A; Yoshida H; Kuma K; Amino N
    Cancer Lett; 2005 Feb; 219(1):91-6. PubMed ID: 15694668
    [TBL] [Abstract][Full Text] [Related]  

  • 5. STT3A, C1orf24, TFF3: putative markers for characterization of follicular thyroid neoplasms from fine-needle aspirates.
    Patel MR; Stadler ME; Deal AM; Kim HS; Shores CG; Zanation AM
    Laryngoscope; 2011 May; 121(5):983-9. PubMed ID: 21520112
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The fifteen percent issue in molecular-based diagnosis of follicular thyroid carcinoma.
    Takano T
    Pathol Int; 2011 Mar; 61(3):165-6. PubMed ID: 21355960
    [No Abstract]   [Full Text] [Related]  

  • 7. Measurement of TFF3 mRNA in aspirates from thyroid nodules using mesh filtration: the first clinical trial in 130 cases.
    Yamada H; Takano T; Kihara M; Hirokawa M; Yoshida H; Watanabe M; Iwatani Y; Hidaka Y; Miyauchi A
    Endocr J; 2012; 59(7):621-30. PubMed ID: 22572548
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Two-miRNA classifiers differentiate mutation-negative follicular thyroid carcinomas and follicular thyroid adenomas in fine needle aspirations with high specificity.
    Stokowy T; Wojtas B; Jarzab B; Krohn K; Fredman D; Dralle H; Musholt T; Hauptmann S; Lange D; Hegedüs L; Paschke R; Eszlinger M
    Endocrine; 2016 Nov; 54(2):440-447. PubMed ID: 27473101
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Can noninvasive follicular thyroid neoplasm with papillary-like nuclear features be distinguished from classic papillary thyroid carcinoma and follicular adenomas by fine-needle aspiration?
    Brandler TC; Zhou F; Liu CZ; Cho M; Lau RP; Simsir A; Patel KN; Sun W
    Cancer Cytopathol; 2017 Jun; 125(6):378-388. PubMed ID: 28296267
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Role of blood and nucleic acid testing in diagnosis of thyroid carcinoma].
    Takano T
    Nihon Rinsho; 2007 Nov; 65(11):1991-5. PubMed ID: 18018560
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Galectin-3: presurgical marker of thyroid follicular epithelial cell-derived carcinomas.
    Saggiorato E; Aversa S; Deandreis D; Arecco F; Mussa A; Puligheddu B; Cappia S; Conticello S; Papotti M; Orlandi F
    J Endocrinol Invest; 2004 Apr; 27(4):311-7. PubMed ID: 15233548
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNA expression array identifies novel diagnostic markers for conventional and oncocytic follicular thyroid carcinomas.
    Dettmer M; Vogetseder A; Durso MB; Moch H; Komminoth P; Perren A; Nikiforov YE; Nikiforova MN
    J Clin Endocrinol Metab; 2013 Jan; 98(1):E1-7. PubMed ID: 23150679
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Trefoil factor 3 immunohistochemical characterization of follicular thyroid lesions from tissue microarray.
    Patel MR; Bryson PC; Shores CG; Hart CF; Thorne LB; Deal AM; Zanation AM
    Arch Otolaryngol Head Neck Surg; 2009 Jun; 135(6):590-6. PubMed ID: 19528408
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clear Cell Variant of a Follicular Thyroid Tumor With Uncertain Malignant Potential: A Case Report.
    Juhlin CC; Bränström R; Shabo I; Höög A
    Int J Surg Pathol; 2019 May; 27(3):290-293. PubMed ID: 30370813
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunohistochemical distinction of follicular thyroid adenomas and follicular carcinomas.
    Bryson PC; Shores CG; Hart C; Thorne L; Patel MR; Richey L; Farag A; Zanation AM
    Arch Otolaryngol Head Neck Surg; 2008 Jun; 134(6):581-6. PubMed ID: 18559722
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Nodule diagnosed as follicular patterned lesion: are biomarkers the promise?].
    Cerutti JM
    Arq Bras Endocrinol Metabol; 2007 Jul; 51(5):832-42. PubMed ID: 17891248
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnostic and prognostic value of cell-cycle regulatory genes in malignant thyroid neoplasms.
    Kebebew E; Peng M; Reiff E; Duh QY; Clark OH; McMillan A
    World J Surg; 2006 May; 30(5):767-74. PubMed ID: 16547620
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High-throughput differential screening of mRNAs by serial analysis of gene expression: decreased expression of trefoil factor 3 mRNA in thyroid follicular carcinomas.
    Takano T; Miyauchi A; Yoshida H; Kuma K; Amino N
    Br J Cancer; 2004 Apr; 90(8):1600-5. PubMed ID: 15083192
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Fine-needle aspiration biopsy of the thyroid nodule: uses and limitations].
    Hayashi N; Kitaoka M
    Nihon Rinsho; 2007 Nov; 65(11):2003-7. PubMed ID: 18018562
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Laser capture microdissection is a valuable tool in the preoperative molecular screening of follicular lesions of the thyroid: an institutional experience.
    Bongiovanni M; Molinari F; Eszlinger M; Paschke R; Barizzi J; Merlo E; Giovanella L; Fasolini F; Cattaneo F; Ramelli F; Mazzucchelli L; Frattini M
    Cytopathology; 2015 Oct; 26(5):288-96. PubMed ID: 25487739
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.